Close

Novavax completes enrolling 30,000 people in U.S. trial of COVID-19 vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to Novavax completes enrolling 30,000 people in U.S. trial of COVID-19 vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 4.19 +0.12 (2.95%)
Previous Close $4.07    52 Week High $9.23 
Open $4.09    52 Week Low $1.16 
Day High $4.36    P/E N/A 
Day Low $4.08    EPS $-0.30 
Volume 3,580,225